FINANCIAL STATEMENTS 128 ASTRAZENECA ANNUAL REPORT AND FORM 20-F INFORMATION 2007 NOTES TO THE FINANCIAL STATEMENTS CONTINUED 6 SEGMENT INFORMATION The Groups activities are in one business segment, pharmaceuticals.
There are no other significant classes of business, either singularly or in aggregate.
Geographic areas The tables below show information by geographic area and, for sales and property, plant and equipment, material countries.
The figures show the sales, operating profit and profit before tax made by companies located in that area country, together with segment assets, segment assets acquired, net operating assets and property, plant and equipment owned by the same companies: export sales and the related profit are included in the area country from which those sales were made.
In the US, sales to three wholesalers accounted for approximately 82% of US sales 2006 three wholesalers accounted for approximately 80%, 2005 three wholesalers accounted for approximately 80%.
Intra-Group pricing is determined on an arms length basis.
2 Net operating assets exclude short term investments, cash, short term borrowings, loans, retirement bene t obligations and non-operating receivables and payables.
Property, plant and equipment 2007 2006 2005 $m $m $m UK 2,490 2,508 2,276 Sweden 2,204 2,104 1,897 US 1,915 1,172 1,176 Rest of the world 1,689 1,669 1,636 Continuing operations 8,298 7,453 6,985 Geographic markets The table below shows turnover in each geographic market in which customers are located.
